FDA approves BioDelivery’s drug for opioid dependence

Article Excerpt: BioDelivery Sciences International Inc said it had received U.S. regulatory approval for its drug, Bunavail, to treat opioid dependence.

Full Article: http://tinyurl.com/q4v9oc8

Article Source: MedCity News